• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 09/29/14

    • 30-Day SEC Yield1

      1.82%
    • Total Net Assets

      $404.2M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2014
  • Portfolio Composition (%)
    as of 09/29/14

    • % of Net Assets
    • Stocks

      99.83
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.17
  • Download All HoldingsAll Holdings (%)as of 09/29/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    416,908
    44,417,37810.99
    Novartis Ag
    NVS US
    427,012
    39,951,2439.88
    Pfizer Inc
    PFE US
    989,993
    29,472,0927.29
    Merck & Co Inc
    MRK US
    392,880
    23,341,0015.77
    Sanofi
    SNY US
    400,056
    22,287,1205.51
    Novo Nordisk A/S
    NVO US
    433,269
    20,970,2205.19
    Glaxosmithkline Plc
    GSK US
    421,083
    19,491,9324.82
    Actavis Plc
    ACT US
    75,811
    18,527,4504.58
    Abbvie Inc
    ABBV US
    313,304
    18,334,5504.54
    Bristol-Myers Squibb Co
    BMY US
    350,779
    18,138,7824.49
    Abbott Laboratories
    ABT US
    417,667
    17,500,2474.33
    Eli Lilly & Co
    LLY US
    267,742
    17,494,2624.33
    Astrazeneca Plc
    AZN US
    239,867
    17,258,4314.27
    Allergan Inc/United States
    AGN US
    90,324
    16,231,2234.02
    Shire Plc
    SHPG US
    61,684
    16,079,1683.98
    Teva Pharmaceutical Industries Ltd
    TEVA US
    270,937
    14,511,3863.59
    Valeant Pharmaceuticals International I
    VRX US
    94,568
    12,318,4283.05
    Mckesson Corp
    MCK US
    61,751
    12,135,3073.00
    Perrigo Co
    PRGO US
    36,583
    5,477,5731.36
    Zoetis Inc
    ZTS US
    138,707
    5,103,0311.26
    Mylan Inc/Pa
    MYL US
    108,570
    4,971,4201.23
    Mallinckrodt Plc
    MNK US
    31,851
    2,864,0420.71
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    35,737
    2,484,4360.61
    Hospira Inc
    HSP US
    42,142
    2,222,9910.55
    Salix Pharmaceuticals Ltd
    SLXP US
    12,253
    1,908,7720.47
    Other/Cash
    698,4400.17
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.